{"id":"W2129405414","doi":"10.1586/era.10.21","title":"Evolution of systemic therapy for advanced pancreatic cancer","year":2010,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gemcitabine; Medicine; Erlotinib; Pancreatic cancer; Oncology; Drug development; Cabozantinib; Targeted therapy; Cancer; Internal medicine; Clinical trial; Drug; Pharmacology; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009766661,0.000572118,0.007144656,0.0002229943,0.00006195006,0.00000473311,0.000426138,0.0004646236,0.0006118774],"category_scores_gemma":[0.0002616915,0.0003573299,0.001361305,0.0005137602,0.0003702136,0.00005877183,0.00002914644,0.0004664349,0.000008386161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000354609,"about_ca_system_score_gemma":0.003126934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001427066,"about_ca_topic_score_gemma":0.000003626853,"domain_scores_codex":[0.9963439,0.0002949121,0.001743522,0.0005604677,0.0005884111,0.0004687816],"domain_scores_gemma":[0.9960474,0.0006996124,0.001306121,0.001056722,0.0007320427,0.000158047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002831854,0.0002237419,0.000148995,0.1595544,0.0007612339,0.000001826919,0.00007685004,1.646793e-8,0.0006162236,0.0001442108,0.001028764,0.8371605],"study_design_scores_gemma":[0.001604719,0.0007880587,0.00003004284,0.2935637,0.0007449363,0.00004560875,0.0000185821,0.000004065238,0.00009421867,0.00001832564,0.7028604,0.0002274448],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002358495,0.9896041,0.0002521039,0.0002091486,0.0004597492,0.008802786,0.0001097247,0.0000297638,0.0002968315],"genre_scores_gemma":[0.00005325185,0.9919806,0.002097666,0.0003621578,0.0005928624,0.004339954,0.00007483803,0.0001092125,0.0003895148],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8369331,"threshold_uncertainty_score":0.9998879,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06803295768521518,"score_gpt":0.4710640762374048,"score_spread":0.4030311185521896,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}